BlackRock Inc. - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 75 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q1 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q4 2022$260,289
-33.1%
2,355,555
-0.2%
0.00%
Q3 2022$389,000
-34.7%
2,359,841
-0.3%
0.00%
Q2 2022$596,000
-56.1%
2,367,100
-7.4%
0.00%
Q1 2022$1,358,000
-13.4%
2,556,573
+0.4%
0.00%
Q4 2021$1,568,000
-40.1%
2,547,153
-0.8%
0.00%
Q3 2021$2,618,000
-39.4%
2,566,443
+8.7%
0.00%
Q2 2021$4,323,000
-61.3%
2,362,071
-58.4%
0.00%
Q1 2021$11,177,000
+71.3%
5,673,664
+8.7%
0.00%
Q4 2020$6,526,000
-38.6%
5,220,525
-11.6%
0.00%
Q3 2020$10,625,000
-79.8%
5,903,239
-5.9%
0.00%
-100.0%
Q2 2020$52,634,000
+74.0%
6,273,466
+8.7%
0.00%
+100.0%
Q1 2020$30,249,000
+2.4%
5,772,447
+6.7%
0.00%0.0%
Q4 2019$29,551,000
+12.0%
5,412,203
-0.1%
0.00%0.0%
Q3 2019$26,383,000
-28.0%
5,417,544
+2.5%
0.00%
-50.0%
Q2 2019$36,623,000
+4.7%
5,284,629
+5.0%
0.00%0.0%
Q1 2019$34,965,000
+16.5%
5,030,953
-2.1%
0.00%0.0%
Q4 2018$30,016,000
-23.8%
5,139,893
-1.5%
0.00%0.0%
Q3 2018$39,412,000
+96.9%
5,220,146
+31.7%
0.00%
+100.0%
Q2 2018$20,015,000
-10.1%
3,963,643
+8.6%
0.00%0.0%
Q1 2018$22,257,000
-12.8%
3,648,579
+1.5%
0.00%0.0%
Q4 2017$25,524,000
+37.4%
3,594,865
+38.4%
0.00%0.0%
Q3 2017$18,576,000
+20.0%
2,598,098
+5.7%
0.00%0.0%
Q2 2017$15,480,000
+182.0%
2,457,215
+269.3%
0.00%
Q1 2017$5,490,000665,4260.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q1 2022
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 3,738,925$23,555,00031.22%
Perceptive Advisors 1,232,500$7,764,0000.39%
IFP Advisors, Inc 1,001,025$6,306,0000.27%
WOODSTOCK CORP 55,489$350,0000.07%
Virtus ETF Advisers LLC 50,795$320,0000.05%
Dynamic Technology Lab Private Ltd 31,431$198,0000.04%
Evanson Asset Management, LLC 20,660$130,0000.03%
Artal Group S.A. 250,000$1,575,0000.03%
GSA CAPITAL PARTNERS LLP 58,800$370,0000.02%
Raymond James Financial Services Advisors, Inc. 426,280$2,686,0000.02%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders